Literature DB >> 26360963

Opioid Use and Risk of Nonvertebral Fractures in Adults With Rheumatoid Arthritis: A Nested Case-Control Study Using Administrative Databases.

Francisco A Acurcio1, Cristiano S Moura2, Sasha Bernatsky2, Louis Bessette3, Elham Rahme2.   

Abstract

OBJECTIVE: To assess the risk of nonvertebral fractures in patients with rheumatoid arthritis (RA) who were exposed to opioids.
METHODS: A population-based, nested case-control study was conducted using health services administrative databases (Quebec, Canada) from 1997 to 2012. Among RA patients, cases of nonvertebral fractures from 2007 to 2012 were identified using a validated algorithm. The date of the first fracture was the index date for the case and his/her matched control. Controls were selected using incidence density sampling and were matched 5:1 to cases for age, sex, and date of RA diagnosis. Opioid exposure was classified as current use, recent past use, remote past use, and nonuse. Conditional logistic regression was used to assess the association of nonvertebral fractures with opioid exposure, adjusting for comorbidity, indicators of RA severity, drugs influencing fracture risk, and health care utilization.
RESULTS: In total, 1,723 cases and 8,046 controls were identified. Among these patients, 2,595 (722 cases and 1,873 controls) had been exposed to opioids. Current use (versus nonuse) increased the risk of nonvertebral fracture. Cumulative current use of opioids according to the quartile distribution was also associated with the risk of nonvertebral fracture: for continuous use for 1-20 days before the index date, odds ratio (OR) 11.49 (95% confidence interval [95% CI] 8.81-14.99); for 21-155 days, OR 1.75 (95% CI 1.31-2.33); for 156-355 days, OR 1.54 (95% CI 1.17-2.04); and for ≥356 days, OR 1.73 (95% CI 1.31-2.30). No association between the risk of nonvertebral fractures and recent past use or remote past use of opioids was observed.
CONCLUSION: Among RA patients, the risk of nonvertebral fracture is increased in those treated with opioids.
© 2016, American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26360963     DOI: 10.1002/art.39422

Source DB:  PubMed          Journal:  Arthritis Rheumatol        ISSN: 2326-5191            Impact factor:   10.995


  9 in total

Review 1.  Skeletal complications of rheumatoid arthritis.

Authors:  L Heinlen; M B Humphrey
Journal:  Osteoporos Int       Date:  2017-08-04       Impact factor: 4.507

Review 2.  Opioids and Chronic Pain: Where Is the Balance?

Authors:  Mellar P Davis; Zankhana Mehta
Journal:  Curr Oncol Rep       Date:  2016-12       Impact factor: 5.075

3.  Higher Medication Adherence and Lower Opioid Use Among Individuals with Autoimmune Disease Enrolled in an Adalimumab Patient Support Program in the United States.

Authors:  A Mark Fendrick; Dendy Macaulay; Debbie Goldschmidt; Harry Liu; Diana Brixner; Tauseef Ali; Manish Mittal
Journal:  Rheumatol Ther       Date:  2021-04-25

4.  Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis.

Authors:  Neil A Accortt; Jennifer Schenfeld; Eunice Chang; Elya Papoyan; Michael S Broder
Journal:  Adv Ther       Date:  2017-08-02       Impact factor: 3.845

5.  Use of prescription opioids among patients with rheumatic diseases compared to patients with hypertension in the USA: a retrospective cohort study.

Authors:  Sarah K Chen; Candace H Feldman; Gregory Brill; Yvonne C Lee; Rishi J Desai; Seoyoung C Kim
Journal:  BMJ Open       Date:  2019-06-19       Impact factor: 2.692

6.  An updated analysis of opioids increasing the risk of fractures.

Authors:  Qiaoning Yue; Yue Ma; Yirong Teng; Yun Zhu; Hao Liu; Shuanglan Xu; Jie Liu; Jianping Liu; Xiguang Zhang; Zhaowei Teng
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

Review 7.  Less Well-Known Consequences of the Long-Term Use of Opioid Analgesics: A Comprehensive Literature Review.

Authors:  Aleksandra Kotlińska-Lemieszek; Zbigniew Żylicz
Journal:  Drug Des Devel Ther       Date:  2022-01-18       Impact factor: 4.162

Review 8.  Chronic Pain after Bone Fracture: Current Insights into Molecular Mechanisms and Therapeutic Strategies.

Authors:  Yuying Zhao; Haoyue Zhang; Nan Li; Jing Li; Linlin Zhang
Journal:  Brain Sci       Date:  2022-08-09

9.  Changes in Opioid Utilization Following Tumor Necrosis Factor Inhibitor Initiation in Patients with Rheumatoid Arthritis.

Authors:  Siyeon Park; Tham T Le; Julia F Slejko; Ester Villalonga-Olives; Eberechukwu Onukwugha
Journal:  Rheumatol Ther       Date:  2019-10-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.